Ironwood Pharmaceuticals IRWD Enterprise value

Enterprise value at other companies

Bausch Health CompaniesBHC

$21.45B-5.6%

ArdelyxARDX

$1.42B+42.3%

Rigel PharmaceuticalsRIGL

$543.41M+96.3%

Mirum Pharmaceuticals, Inc.MIRM

$6.89B+193%

Ionis PharmaceuticalsIONS

$13.02B+91.2%

Neurocrine BiosciencesNBIX

$13.41B+18.5%

FAQ

What is Ironwood Pharmaceuticals's enterprise value?

Ironwood Pharmaceuticals (IRWD) reported enterprise value of $625.76M in Q2 2026.

How has Ironwood Pharmaceuticals's enterprise value changed year-over-year?

Ironwood Pharmaceuticals's enterprise value increased by 162.6% year-over-year, from $238.27M to $625.76M.

What is the long-term trend for Ironwood Pharmaceuticals's enterprise value?

Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's enterprise value has grown at a -18.3% compound annual growth rate (CAGR), from $1.49B to $545.57M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.